These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16361319)

  • 1. Activation of Vgamma9Vdelta2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication.
    Agrati C; Alonzi T; De Santis R; Castilletti C; Abbate I; Capobianchi MR; D'Offizi G; Siepi F; Fimia GM; Tripodi M; Poccia F
    Int Immunol; 2006 Jan; 18(1):11-8. PubMed ID: 16361319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo interferon-alpha/ribavirin treatment modulates Vγ9Vδ2 T-cell function during chronic HCV infection.
    Cimini E; Bonnafous C; Sicard H; Vlassi C; D'Offizi G; Capobianchi MR; Martini F; Agrati C
    J Interferon Cytokine Res; 2013 Mar; 33(3):136-41. PubMed ID: 23308376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-α improves phosphoantigen-induced Vγ9Vδ2 T-cells interferon-γ production during chronic HCV infection.
    Cimini E; Bonnafous C; Bordoni V; Lalle E; Sicard H; Sacchi A; Berno G; Gioia C; D'Offizi G; Visco Comandini U; Vlassi C; Capobianchi MR; Martini F; Agrati C
    PLoS One; 2012; 7(5):e37014. PubMed ID: 22629350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated V gamma 9V delta 2 T cells trigger granulocyte functions via MCP-2 release.
    Agrati C; Cimini E; Sacchi A; Bordoni V; Gioia C; Casetti R; Turchi F; Tripodi M; Martini F
    J Immunol; 2009 Jan; 182(1):522-9. PubMed ID: 19109184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent gamma delta T-cell dysfunction in chronic HCV infection despite direct-acting antiviral therapy induced cure.
    Ghosh A; Mondal RK; Romani S; Bagchi S; Cairo C; Pauza CD; Kottilil S; Poonia B
    J Viral Hepat; 2019 Sep; 26(9):1105-1116. PubMed ID: 31074195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of BCG-induced Th1 immune response through Vgamma9Vdelta2 T cell activation with non-peptidic drugs.
    Martino A; Casetti R; Poccia F
    Vaccine; 2007 Jan; 25(6):1023-9. PubMed ID: 17118497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?
    Gougeon ML; Malkovsky M; Casetti R; Agrati C; Poccia F
    Vaccine; 2002 May; 20(15):1938-41. PubMed ID: 11983250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replication.
    Cimini E; Bordoni V; Sacchi A; Visco-Comandini U; Montalbano M; Taibi C; Casetti R; Lalle E; D'Offizi G; Capobianchi MR; Agrati C
    Virus Res; 2018 Jan; 243():31-35. PubMed ID: 29029951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer.
    Wada I; Matsushita H; Noji S; Mori K; Yamashita H; Nomura S; Shimizu N; Seto Y; Kakimi K
    Cancer Med; 2014 Apr; 3(2):362-75. PubMed ID: 24515916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients.
    Cabillic F; Toutirais O; Lavoué V; de La Pintière CT; Daniel P; Rioux-Leclerc N; Turlin B; Mönkkönen H; Mönkkönen J; Boudjema K; Catros V; Bouet-Toussaint F
    Cancer Immunol Immunother; 2010 Nov; 59(11):1611-9. PubMed ID: 20582413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation.
    Devilder MC; Maillet S; Bouyge-Moreau I; Donnadieu E; Bonneville M; Scotet E
    J Immunol; 2006 Feb; 176(3):1386-93. PubMed ID: 16424165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.
    Poccia F; Gioia C; Martini F; Sacchi A; Piacentini P; Tempestilli M; Agrati C; Amendola A; Abdeddaim A; Vlassi C; Malkovsky M; D'Offizi G
    AIDS; 2009 Mar; 23(5):555-65. PubMed ID: 19238075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy.
    Poccia F; Agrati C; Martini F; Mejia G; Wallace M; Malkovsky M
    Immunol Lett; 2005 Aug; 100(1):14-20. PubMed ID: 16115692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
    Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
    J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.
    Meraviglia S; Eberl M; Vermijlen D; Todaro M; Buccheri S; Cicero G; La Mendola C; Guggino G; D'Asaro M; Orlando V; Scarpa F; Roberts A; Caccamo N; Stassi G; Dieli F; Hayday AC
    Clin Exp Immunol; 2010 Aug; 161(2):290-7. PubMed ID: 20491785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons.
    Agrati C; D'Offizi G; Narciso P; Abrignani S; Ippolito G; Colizzi V; Poccia F
    Mol Med; 2001 Jan; 7(1):11-9. PubMed ID: 11474123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vγ9Vδ2 T cells, αβ CD8+ T cells, regulatory T cells, and dendritic cells.
    Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
    J Immunol; 2011 Aug; 187(4):1578-90. PubMed ID: 21753152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminobisphosphonates Synergize with Human Cytomegalovirus To Activate the Antiviral Activity of Vγ9Vδ2 Cells.
    Daguzan C; Moulin M; Kulyk-Barbier H; Davrinche C; Peyrottes S; Champagne E
    J Immunol; 2016 Mar; 196(5):2219-29. PubMed ID: 26819204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential requirements of zoledronate-induced cytokine and γδ T cell proliferative responses.
    Nussbaumer O; Gruenbacher G; Gander H; Komuczki J; Rahm A; Thurnher M
    J Immunol; 2013 Aug; 191(3):1346-55. PubMed ID: 23794630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.